From the academy
Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures

https://doi.org/10.1016/j.jaad.2020.07.087Get rights and content

Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the United States population. This guideline addresses important clinical questions that arise in psoriasis management and care and provides recommendations based on the available evidence. The treatment of psoriasis with topical agents and with alternative medicine will be reviewed, emphasizing treatment recommendations and the role of dermatologists in monitoring and educating patients regarding benefits as well as risks that may be associated. This guideline will also address the severity assessment methods of psoriasis in adults.

Key words

alternative medicine (AM)
clinical guidelines for psoriasis
dermatology
guidelines
psoriasis
severity assessment
skin disease
topical agents

Abbreviations used

AAD
American Academy of Dermatology
AM
alternative medicine
AV
Aloe vera
BSA
body surface area
DLQI
Dermatology Life Quality Index
FDA
Food and Drug Administration
HM
herbal medicine
LCD
liquor carbonis detergens
NB-UVB
narrow band ultraviolet B
NPF
National Psoriasis Foundation
PASI
Psoriasis Area Severity Index
PGA
Physician's Global Assessment
PSI
Psoriasis Symptom Inventory
RCT
randomized controlled trial
UVA
ultraviolet A
UVB
ultraviolet B
US
United States
WG
workgroup

Cited by (0)

Funding sources: None.

Conflicts of interest: Listed in text.

IRB approval status: Not applicable.

Reprints not available from the authors.

View Abstract